Review



ppb ct3g cerp2 tsc22d3  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Addgene inc ppb ct3g cerp2 tsc22d3
    Ppb Ct3g Cerp2 Tsc22d3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ppb ct3g cerp2 tsc22d3/product/Addgene inc
    Average 90 stars, based on 6 article reviews
    ppb ct3g cerp2 tsc22d3 - by Bioz Stars, 2026-05
    90/100 stars

    Images



    Similar Products

    ppb ct3g cerp2 tsc22d3  (Addgene inc)
    90
    Addgene inc ppb ct3g cerp2 tsc22d3
    Ppb Ct3g Cerp2 Tsc22d3, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ppb ct3g cerp2 tsc22d3/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    ppb ct3g cerp2 tsc22d3 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    plasmids 19291  (Addgene inc)
    90
    Addgene inc plasmids 19291
    Plasmids 19291, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plasmids 19291/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    plasmids 19291 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    pgl2 e cad 108 ebox mut luc  (Addgene inc)
    90
    Addgene inc pgl2 e cad 108 ebox mut luc
    (A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad <t>(−108)-WT-Luc)</t> or mutated (E-cad (−108) <t>Ebox</t> Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.
    Pgl2 E Cad 108 Ebox Mut Luc, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pgl2 e cad 108 ebox mut luc/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    pgl2 e cad 108 ebox mut luc - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    ppb ct3g cerp2 hoxc9  (Addgene inc)
    90
    Addgene inc ppb ct3g cerp2 hoxc9
    (A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad <t>(−108)-WT-Luc)</t> or mutated (E-cad (−108) <t>Ebox</t> Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.
    Ppb Ct3g Cerp2 Hoxc9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ppb ct3g cerp2 hoxc9/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    ppb ct3g cerp2 hoxc9 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    ppb ct3g cerp2 nr5a1  (Addgene inc)
    90
    Addgene inc ppb ct3g cerp2 nr5a1
    (A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad <t>(−108)-WT-Luc)</t> or mutated (E-cad (−108) <t>Ebox</t> Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.
    Ppb Ct3g Cerp2 Nr5a1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ppb ct3g cerp2 nr5a1/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    ppb ct3g cerp2 nr5a1 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    ppb ct3g cerp2 elk1  (Addgene inc)
    90
    Addgene inc ppb ct3g cerp2 elk1
    (A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad <t>(−108)-WT-Luc)</t> or mutated (E-cad (−108) <t>Ebox</t> Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.
    Ppb Ct3g Cerp2 Elk1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ppb ct3g cerp2 elk1/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    ppb ct3g cerp2 elk1 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    ppb ct3g cerp2 nr1h2  (Addgene inc)
    90
    Addgene inc ppb ct3g cerp2 nr1h2
    (A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad <t>(−108)-WT-Luc)</t> or mutated (E-cad (−108) <t>Ebox</t> Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.
    Ppb Ct3g Cerp2 Nr1h2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ppb ct3g cerp2 nr1h2/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    ppb ct3g cerp2 nr1h2 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    ppb ct3g cerp2 egr1  (Addgene inc)
    90
    Addgene inc ppb ct3g cerp2 egr1
    (A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad <t>(−108)-WT-Luc)</t> or mutated (E-cad (−108) <t>Ebox</t> Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.
    Ppb Ct3g Cerp2 Egr1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ppb ct3g cerp2 egr1/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    ppb ct3g cerp2 egr1 - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    ppb ct3g cerp2 maff  (Addgene inc)
    90
    Addgene inc ppb ct3g cerp2 maff
    (A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad <t>(−108)-WT-Luc)</t> or mutated (E-cad (−108) <t>Ebox</t> Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.
    Ppb Ct3g Cerp2 Maff, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ppb ct3g cerp2 maff/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    ppb ct3g cerp2 maff - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad (−108)-WT-Luc) or mutated (E-cad (−108) Ebox Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.

    Journal: bioRxiv

    Article Title: Autophagy regulates tumor growth and metastasis

    doi: 10.1101/2023.10.31.564991

    Figure Lengend Snippet: (A) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad (−108)-WT-Luc) or mutated (E-cad (−108) Ebox Mut-Luc) Ebox site in cells with or without Atg5 knockout. (B) Immunoblotting in cells with or without Atg5 knockout. (C-D) Immunofluorescence assay of p62/Twist1 (C) or LC3/Twist1 (D) in cells with or without Atg5 knockout treated with or without rapamycin (500 nM) for 6 h. Scale bar, 10 μm. DAPI is used as the nuclear counterstain. (E-F) Immunoblotting in cells with or without Atg5 knockout treated with or without CHX (100 μg/ml, E) or MG132 (10 μM, F) over a time course. (F) Immunoblotting in mouse skin with or without Atg7 knockout. (H) Immunoblotting in cells with or without Atg7 knockout in combination with Atg7 overexpression.

    Article Snippet: PGL2 E-cad (108) WT-Luc and PGL2 E-cad (108) Ebox Mut-Luc were kindly provided by Dr. Eric R. Fearon (Addgene plasmids 19291 and 19290)( ).

    Techniques: Luciferase, Reporter Assay, Knock-Out, Western Blot, Immunofluorescence, Over Expression

    (A) Immunoblotting in A431 cells with or without overexpression of p62 and/or Twist1. (B) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad (−108) WT-Luc) or mutated (E-cad (−108) Mut-Luc) Ebox site in cells as in A. (C) Wound healing assay of cell migration in cells as in A. (D) MTS assay of cells proliferation of cells as in A. (E) Tumor growth from cells as in A. (F) Number of lung tumor nodules per at 14 weeks following injection. (G) Immunoblotting in A375 cells with or without p62 overexpression. (H) Tumor growth from cells as in G. (I) Immunoblotting in A375 cells transfected with or without knockdown of Atg7 or p62. (J) Tumor growth from cells as in I. (K) Immunoblotting in HaCaT cells with or without p62 knockdown and treated with or without EGF/TGF-β)over a time course. (L) qRT-PCR analysis of Twist1 in HaCaT as in K treated with EGF/TGF-β for 48 h. (M) qRT-PCR analysis of p62. Data are shown from three independent experiments (mean±S.D.). n=3. *, P <0.05; compared with WT Con cells (B); #, P <0.05; compared with the WT group (B); *, P <0.05; compared with the Con, A431-p62, and A431-Twist1 groups (E); **, P <0.01; compared with the A431-Twist1 group (F).

    Journal: bioRxiv

    Article Title: Autophagy regulates tumor growth and metastasis

    doi: 10.1101/2023.10.31.564991

    Figure Lengend Snippet: (A) Immunoblotting in A431 cells with or without overexpression of p62 and/or Twist1. (B) Luciferase reporter assay of the E-cadherin promoter with an intact (E-cad (−108) WT-Luc) or mutated (E-cad (−108) Mut-Luc) Ebox site in cells as in A. (C) Wound healing assay of cell migration in cells as in A. (D) MTS assay of cells proliferation of cells as in A. (E) Tumor growth from cells as in A. (F) Number of lung tumor nodules per at 14 weeks following injection. (G) Immunoblotting in A375 cells with or without p62 overexpression. (H) Tumor growth from cells as in G. (I) Immunoblotting in A375 cells transfected with or without knockdown of Atg7 or p62. (J) Tumor growth from cells as in I. (K) Immunoblotting in HaCaT cells with or without p62 knockdown and treated with or without EGF/TGF-β)over a time course. (L) qRT-PCR analysis of Twist1 in HaCaT as in K treated with EGF/TGF-β for 48 h. (M) qRT-PCR analysis of p62. Data are shown from three independent experiments (mean±S.D.). n=3. *, P <0.05; compared with WT Con cells (B); #, P <0.05; compared with the WT group (B); *, P <0.05; compared with the Con, A431-p62, and A431-Twist1 groups (E); **, P <0.01; compared with the A431-Twist1 group (F).

    Article Snippet: PGL2 E-cad (108) WT-Luc and PGL2 E-cad (108) Ebox Mut-Luc were kindly provided by Dr. Eric R. Fearon (Addgene plasmids 19291 and 19290)( ).

    Techniques: Western Blot, Over Expression, Luciferase, Reporter Assay, Wound Healing Assay, Migration, MTS Assay, Injection, Transfection, Knockdown, Quantitative RT-PCR